NEBULA

Description
Class IIa medical device (Directive 93/42/EEC).
A complete solution for the treatment of upper and lower respiratory tract conditions, ideal for the whole family. Nebula, thanks to its two different aerosol ampoules, allows the administration of the drug directly to the target organ (topical therapy).
The Rinowash terminal for washing and treating the upper respiratory tract produces particles with a diameter of 18 mcm that are deposited in the nasal cavity up to the nasopharynx for the treatment of rhinitis, rhinosinusitis and upper respiratory tract infections.
Nebulizer Nebula Spacer with volumetric mouthpiece for the lower airways, ensuring bronchial deposition of the nebulized drug. It produces particles with sizes between 1 and 5 micrometers, which reach even the most remote areas, such as pulmonary alveoli and bronchi.
Pediatric mask for children under 5 years of age, for the treatment of lower respiratory tract.
Complete therapy for the upper and lower respiratory tract. Professional performance that guarantees safe and effective therapy. Reduced dispersion of drugs into the environment. Short therapy duration. Durable and long-lasting materials.
Technical specifications
- Rinowash: MMAD 18 mcm (*)
- Nebula spacer: MMAD 1.9 mcm (*)
Minimum nebulization: 0.3 ml/min
- Device
Continuous operation
Maximum air pressure: 2.7 bar
Maximum air flow: 12 l/min
Noise level at 1 m: 57 dBA (according to UNI EN 13544-1)
Base unit dimensions: 230x180x185 mm
Base unit weight: 3 kg
(*) The values ​​indicated refer to the use of saline solution (0.9% NaCl): they may vary depending on the drug used. The values ​​indicated do not apply to drugs released in suspension or with high viscosity. In this case, the information should be requested from the drug supplier. For more information, see the user manual. Measured with API Aerosizer MACH2.

Format
1 piece.

Code 401123